At Atley's Radiochemistry department, we develop novel and cutting edge At-211 radiochemistry, support the development and validation of Atley's hardware products, and help our customers in the development and automation of radiopharmaceutical manufacturing processes.
Atley Solutions is the world leader in commercial products and services for the development and manufacturing of radiopharmaceuticals based on the alpha emitting radionuclide astatine-211. These radiopharmaceuticals are used in Targeted Alpha Therapy, a promising treatment for disseminated cancer.
Targeted Alpha Therapy has the potential to improve and save millions of lives. For this to happen, Atley is needed.
Let’s recruit together and find your next colleague.